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Introduction
============

Endochondral ossification is the process by which most long bones of the body are formed ([@bib39]). During endochondral ossification, mesenchymal cells first aggregate to form condensations ([@bib14]). The cells in the center of these condensations differentiate into chondrocytes, forming the cartilaginous template, whereas the undifferentiated cells at the periphery form the surrounding perichondrium ([@bib17]). After formation of the cartilage template, the innermost chondrocytes differentiate into hypertrophic chondrocytes and the cells of the inner layer of the perichondrium differentiate into osteoblasts ([@bib24]; [@bib37]), forming a bone collar around the cartilaginous core ([@bib5]). The hypertrophic cells secrete a distinct ECM that gradually becomes calcified ([@bib38]). This specialized matrix allows for vascular invasion from the bone collar and the entry of osteoclasts and osteoblasts that degrade the mineralized cartilage matrix and deposit bone ([@bib36]). Apoptosis of hypertrophic cells and the deposition of a matrix rich in type I collagen (Col I) results in two opposing growth plates that allow for longitudinal bone growth in both directions. This process is in contrast to the craniofacial skeleton bones that are formed by intramembranous ossification, where mesenchymal cells directly differentiate into bone without an intermediate cartilage template.

In this paper, we have identified site-1 protease (S1P) as a new player involved in regulating endochondral ossification. S1P (also known as membrane-bound transcription factor protease, site 1) is a proprotein convertase and a key member of the regulated intramembrane proteolysis pathway involved in the unfolded protein response and cholesterol homeostasis ([@bib3]). A role for S1P in cartilage development was shown through the study of the zebrafish *gonzo* mutant ([@bib41]), which has both lipid and skeletal abnormalities. S1P plays a critical role in the processing of the sterol regulatory element binding proteins (SREBP-1a, -1c, and -2; [@bib9]). SREBPs are membrane-bound transcription factors in the ER and regulate cholesterol and fatty acid biosynthesis and uptake. When cholesterol levels are high, SREBP is retained in the ER membrane as a complex with the sterol-sensing protein SREBP cleavage--activating protein (SCAP) and the retention protein INSIG (insulin induced gene). When cholesterol levels drop, the SREBP--SCAP complex dissociates from INSIG and translocates to the Golgi bodies, where SREBP is sequentially cleaved by S1P and S2P to release the amino-terminal domain of SREBP containing the basic helix-loop-helix leucine zipper region. The basic helix-loop-helix leucine zipper region translocates to the nucleus to bind to cis-acting sterol responsive elements. In a similar fashion, S1P is also involved in the activation of other ER membrane-bound proteins such as activating transcription factor 6 (ATF6; [@bib15]; [@bib53]), old astrocyte specifically induced substance (OASIS; [@bib34]), and cAMP-responsive element binding protein H (CREBH; [@bib58]), which are transcription factors for the unfolded protein response target genes.

To elucidate the role of S1P in all aspects of skeletal development, we created cartilage-specific S1P knockout mice (S1P*^cko^*) using a *Col2a1* promoter. S1P*^cko^* mice die shortly after birth and exhibit severe chondrodysplasia. The cartilage matrix is abnormal in S1P*^cko^* mice with defects in Col II protein secretion and assimilation into the matrix, and endochondral bone formation is completely absent. This is the first example of a defect in a regulated intramembrane proteolysis enzyme that affects cartilage development and endochondral ossification in mice. Deletions of various matrix metalloproteinases (MMPs), such as MMP13 or MMP9 ([@bib20]; [@bib45]), thought to be important in bone morphogenesis did not abolish endochondral ossification. Thus, S1P is a unique enzyme that plays an integral role in skeletal development.

Results
=======

S1P^*cko*^ mice exhibit severe chondrodysplasia
-----------------------------------------------

To produce mice lacking S1P in the cartilage, the Col2-Cre recombinase was used to delete exon 2 of S1P. S1P^*f*/+^;Col2-Cre mice were bred with S1P*^f/f^* mice to generate conditional knockout S1P*^f/f^*;Col2-Cre (S1P*^cko^*) mice. S1P*^cko^* mice exhibit severe chondrodysplasia ([Fig. 1 A](#fig1){ref-type="fig"}) with deformed limbs, a protruding tongue ([Fig. 1 B](#fig1){ref-type="fig"}), and a distended belly and die during or shortly after birth. All structural elements are present in S1P*^cko^* mice but are considerably smaller than in wild-type (WT) mice ([Fig. 1 C](#fig1){ref-type="fig"}). [Fig. 1 D](#fig1){ref-type="fig"} shows a detailed analysis of the skeletal elements. The smaller skull in S1P*^cko^* mice, caused by a shortened chondocranial base coupled with foreshortened mandibles and upper jaw bones, appears to be responsible for the protrusion of the tongue. The skull bones show increased sensitivity to potassium hydroxide (used for clearing the tissue during skeletal staining) that resulted in the dissolution of the bones in the back of the skull ([Fig. 1 D](#fig1){ref-type="fig"}, arrow), which remain intact in the WT. The chest cavity is small and presses the internal organs into the abdominal cavity, giving the belly a distended appearance. The smaller chest cavity probably causes acute neonatal respiratory distress and subsequent lethality. The skewed orientation of the limbs, particularly the hind limbs, suggests anomalous articular joint development. Heterozygotes (S1P^*f*/+^;Col2-Cre) appear normal and do not show any phenotype (unpublished data).

![**Severe chondrodysplasia in S1P*^cko^* mice.** (A) Newborn S1P*^cko^* mice (right) exhibit severe chondrodysplasia as compared with WT mice (left). (B) S1P*^cko^* mice have a smaller skull and foreshortened mandibles, which results in the protrusion of the tongue. (C) Whole animal skeletal preparation of WT (left) and S1P*^cko^* (right) newborns. (D) The skeletal patterning in S1P*^cko^* mice is similar to WT mice, but all the skeletal elements are smaller. The arrow points to the furrow that is formed in S1P*^cko^* skull (absent in WT) during skeletal staining, which suggests a lack of structural integrity of the skull bones.](jcb1790687f01){#fig1}

To confirm that the phenotype in S1P*^cko^* mice is caused by a lack of S1P, we analyzed the expression of the *S1P* gene in chondrocytes in different developmental stages by in situ hybridization ([Fig. 2](#fig2){ref-type="fig"}). *S1P* is abundantly expressed in the chondrocytes in the developing WT forelimb at all stages ([Fig. 2, A--D](#fig2){ref-type="fig"}). The heterozygotes show drastic reduction in *S1P* expression in chondrocytes but show normal bone development, with expression in bone and surrounding tissues intact ([Fig. 2, E and F](#fig2){ref-type="fig"}). As expected, the homozygous knockout (S1P*^cko^*) does not show any *S1P* expression in skeletal tissues ([Fig. 2 H](#fig2){ref-type="fig"}). These data suggest that the mutant phenotype could be directly attributed to the efficient knockout of both copies of *S1P* in the cartilage in S1P*^cko^* mice.

![**In situ hybridization analysis of *S1P* gene.** Expression of *S1P* is ubiquitous, although expression is stronger in the skeletal elements with use of the full-length *S1P* in situ probe (A--E). (A) *S1P* is expressed abundantly in immature chondrocytes in the humerus (hu), radius (r), and ulna (u) in the forelimb of the WT at E13.5. (B) At E14.5, expression of *S1P* decreases considerably in the hypertrophic (h) chondrocytes in the humerus of the WT. (C) At E15.5, expression of *S1P* is seen in the newly deposited bone (b) in the WT. (D) At E18.5, expression of *S1P* is seen throughout the humerus, including the hypertrophic cells (bracket) and bone trabeculae in the WT. (E) Expression of *S1P* is drastically reduced in the chondrocytes of the heterozygotes (S1P^*f*/+^;Col2-Cre) but is normal in bone and surrounding tissue (E18.5) using the full-length probe or against exon 2 of *S1P* (F). Brackets indicate hypertrophic cells. In situ analysis for *S1P* using the exon 2 probe in E13.5 WT (G) and S1P*^cko^* (H) forelimb. In S1P*^cko^* mice, expression signaling from exon 2 is absent in the skeletal tissues. s, scapula. Bar, 500 μm.](jcb1790687f02){#fig2}

Lack of organized hypertrophy and endochondral ossification in S1P^*cko*^ mice
------------------------------------------------------------------------------

As S1P*^cko^* mice die during or shortly after birth, we conducted a histological analysis of various skeletal elements at different embryonic stages. S1P*^cko^* mice lack an organized hypertrophic zone and endochondral ossification, as shown for the humerus at different stages ([Fig. 3](#fig3){ref-type="fig"}). At embryonic day (E) 13.5, no major differences are observed in the morphology of the humerus between S1P*^cko^* and WT mice. At E13.75 (7 h after E13.5), the WT humerus increased in size and the chondrocytes in the center initiated hypertrophy. S1P*^cko^* mice, however, showed only a slight increase in the size of the humerus at E13.75. The transition from proliferating to hypertrophic cells appears to be initiated but does not progress to hypertrophy, though a change in morphology of the cells at the center of the humerus is noticeable. At E14.5, the humerus in WT mice has considerably increased in size and hypertrophy is completely established. In S1P*^cko^* mice, however, the transition from proliferating to hypertrophic cells is still incomplete at E14.5. At E15.5, endochondral bone is observed in WT mice with the establishment of a growth plate. However, at E15.5, S1P*^cko^* mice still do not exhibit an organized hypertrophic zone. Notably, there is no endochondral ossification or growth plate, and, consequently, the humerus is small compared with the WT. In the absence of endochondral bone, however, there is an exuberant growth of the bone collar ([Fig. 3](#fig3){ref-type="fig"}, arrow).

![**Lack of organized hypertrophy and endochondral bone formation in S1P*^cko^* mice.** WT and S1P*^cko^* forelimb sections were stained with Safranin O, Fast green, and hematoxylin at various time points. The humerus is shown in all panels. Hypertrophic chondrocytes are visible in WT mice as early as E13.75 (7 h after E13.5). These hypertrophic cells are structured into a distinct hypertrophic zone that is missing in S1P*^cko^* mice. Endochondral bone is evident in WT but absent in S1P*^cko^* mice at E15.5; in the absence of endochondral bone, an exuberant bone collar is formed (arrow). At E18.5, the exuberant bone collar often impinges into the diaphysis and bisects the cartilage. Bar, 200 μm. (insets) High magnification pictures showing the morphology of the chondrocytes near the center of the limb at E13.5; the morphology of hypertrophic cells at E13.75; the junction of the proliferating and hypertrophic cells at E14.5; the junction of the bone and hypertrophic cells for WT; and the center of the limb for the mutant at E15.5. Bar, 50 μm.](jcb1790687f03){#fig3}

At E18.5, it is clear that S1P*^cko^* mice suffer from a lack of endochondral bone formation and a structured growth plate, rather than a delay. At this stage, the exuberant bone collar often impinges into the diaphysis and bisects it. A lack of endochondral ossification is also observed in the hind limbs, sternum, ribs, and spine (Fig. S1, available at <http://www.jcb.org/cgi/content/full/jcb.200708092/DC1>). Although a hypertrophic zone is not seen in S1P*^cko^* mice, they have the ability to make hypertrophic cells, which is more distinguishable in later developmental stages (Fig. S2). In summary, a lack of organized endochondral ossification is observed in all skeletal elements in S1P*^cko^* mice because of the disruption of S1P activity.

Indian hedgehog (Ihh) signaling is intact in S1P^*cko*^ mice
------------------------------------------------------------

Because of a lack of endochondral ossification in S1P*^cko^* mice, we examined Ihh signaling, which is known to be an essential regulator of chondrocyte proliferation and hypertrophic differentiation. Ihh\'s function is thought to be dependent on lipophilic modifications critical for the spatially restricted localization of Ihh signaling ([@bib11]). In the growth plate, Ihh is distributed in a gradient that is necessary for coordinated chondrocyte proliferation and differentiation ([@bib25]). As cholesterol and fatty acid synthesis is likely to be affected in chondrocytes because of the absence of S1P, it could lead to defects in Ihh signaling. A defect in Ihh signaling is associated with a decrease in chondrocyte proliferation ([@bib44]). Thus, to analyze the nature of Ihh signaling in our model, we labeled proliferating chondrocytes with BrdU at E14.5 ([Fig. 4, A and B](#fig4){ref-type="fig"}). Notably, at E14.5, analysis of the proliferating BrdU-labeled cells revealed that both WT and S1P*^cko^* mice exhibit nearly identical rates of proliferation ([Fig. 4 C](#fig4){ref-type="fig"}). Moreover, WT and S1P*^cko^* proliferating chondrocytes displayed the ability to exit the cell cycle, as seen by a lack of BrdU incorporation as they progressed toward hypertrophic differentiation ([Fig. 4, A and B](#fig4){ref-type="fig"}).

![**Intact Ihh signaling in S1P*^cko^* mice.** (A and B) IHC with anti-BrdU antibodies, showing the presence of actively proliferating, BrdU-labeled chondrocytes in the proximal region of the humerus in WT (A) and S1P*^cko^* (B) mice. In both WT and S1P*^cko^* mice, the initiation of hypertrophic differentiation caused by exit from the cell cycle is visible as a lack of BrdU incorporation (the dotted line marks the end of BrdU incorporation). (C) BrdU incorporation in the proximal region of the humerus in WT and S1P*^cko^* mice, shown here as a percentage of BrdU-positive nuclei in the proliferative zone at E14.5. Error bars represent mean + SD. The WT value is arbitrarily assigned as 1. (D--I) In situ hybridization analyses for *Ptc-1* at E14.5 (D and E), *PTHrP* at E13.5 (F and G), and *BSP* at E13.5 (H and I) suggesting the presence of intact Ihh signaling in S1P*^cko^* mice. Bars: (A and B) 200 μm; (D--I) 500 μm.](jcb1790687f04){#fig4}

The *Ihh* null mutant is also characterized by a lack of expression of its receptor and transcriptional target *Patched-1* (*Ptc-1*) and *parathyroid hormone-related peptide* (*PTHrP*; [@bib44]). PTHrP and its receptor PTHrP-R play important roles in the control of hypertrophic differentiation ([@bib26]; [@bib40]). Therefore, we analyzed the expression of *Ptc-1* and *PTHrP* in S1P*^cko^* mice by in situ hybridization. Expression of both *Ptc-1* ([Fig. 4 E](#fig4){ref-type="fig"}) and *PTHrP* ([Fig. 4 G](#fig4){ref-type="fig"}) is seen in S1P*^cko^* mice, though the expression of *Ptc-1* is not completely similar to WT mice and *PTHrP* appears slightly reduced. Ihh is also required to establish the bone collar by regulating the differentiation of the perichondrial mesenchymal cells into osteoblast progenitors ([@bib44]). Consequently, *Ihh* null mutants do not form a bone collar. Therefore, we studied bone collar formation at E13.5 by analyzing the expression of *bone sialoprotein* (*BSP*), a major structural protein of the bone matrix specifically expressed by maturing osteoblasts. Notably, both WT and S1P*^cko^* mice displayed a timely expression of *BSP* in the developing bone collar at E13.5 ([Fig. 4, H and I](#fig4){ref-type="fig"}). Collectively with *Ptc-1* and *PTHrP* expression, these data suggest that Ihh signaling is intact in S1P*^cko^* mice.

Hypertrophic chondrocyte differentiation is incomplete in S1P^*cko*^ mice
-------------------------------------------------------------------------

Hypertrophic differentiation begins with the proliferating chondrocytes exiting the cell cycle and beginning to express *Ihh* and *Runx2* to form the prehypertrophic cells, which exhibit a decreased expression of *Col2*. The fully differentiated hypertrophic chondrocytes are large, no longer express *Col2*, and are characterized by the expression of *Col10* and *VEGF*. In S1P*^cko^* mice, hypertrophic differentiation is initiated as chondrocytes exit the cell cycle and no longer incorporate BrdU ([Fig. 4 B](#fig4){ref-type="fig"}). However, under higher magnification, this region in E14.5 S1P*^cko^* mice does not show the same morphology as in the WT ([Fig. 5](#fig5){ref-type="fig"}). In the WT humerus ([Fig. 5 A](#fig5){ref-type="fig"}), there is a clear definition of the hypertrophic zone. Above the hypertrophic zone, proliferating chondrocytes are seen organized in groups of columnar chondrocytes. Between these groups, there is an abundant matrix that stains a deep red. In S1P*^cko^* mice ([Fig. 5 B](#fig5){ref-type="fig"}), however, columnar organization of the cells is absent. Chondrocytes are present in a random configuration and are more densely packed. Although a few enlarged cells are present, a distinct hypertrophic zone is absent.

![**A molecular analysis of hypertrophic differentiation in S1P*^cko^* mice.** The prehypertrophic and hypertrophic zones in S1P*^cko^* mice are not well defined. (A and B) The humerus of WT (A) and S1P*^cko^* (B) mice at E14.5 was stained with Safranin O, Fast green, and hematoxylin. The proliferative to hypertrophic zones are shown in both cases. The chondrocytes are randomly oriented in S1P*^cko^* mice and do not acquire the characteristic hypertrophic phenotype seen in the WT in spite of *Runx2* (D) and *Col10* (J) expression. In situ hybridization analyses in adjacent sections of the WT and S1P*^cko^* humerus at E14.5 for *Runx2* (C and D), *Ihh* (E and F), *PTHrP-R* (G and H), and *Col10* (I and J). Bars: (A and B) 50 μm; (C--J) 500 μm.](jcb1790687f05){#fig5}

To analyze hypertrophic differentiation in S1P*^cko^* mice, we performed a series of in situ hybridizations on E14.5 humerus serial sections. First, we analyzed the expression of *Runx2*. Runx2 is a powerful positive regulator of chondrocyte maturation into hypertrophy, and *Runx2* null mice exhibit an absence of both endochondral and intramembranous ossification because of an arrest in osteoblastogenesis ([@bib8]; [@bib24]). By in situ analysis, S1P*^cko^* mice showed an expression pattern for *Runx2* that is similar to the WT in that expression is seen in the perichondrium and presumptive prehypertrophic and hypertrophic cells ([Fig. 5, C and D](#fig5){ref-type="fig"}). To better define the prehypertrophic and hypertrophic regions, we analyzed the expression of *Ihh* and *PTHrP-R* in prehypertrophic cells and *Col10*, which is expressed only by hypertrophic cells. In WT mice, the *Ihh*- ([Fig. 5 E](#fig5){ref-type="fig"}) and *PTHrP-R*--expressing ([Fig. 5 G](#fig5){ref-type="fig"}) prehypertrophic cells and the *Col10*-expressing ([Fig. 5 I](#fig5){ref-type="fig"}) hypertrophic cells form well-defined regions, with the prehypertrophic cells always lying proximal (from the humerus head) to the hypertrophic cells. In S1P*^cko^* mice, however, such well-defined regions are absent. Zones expressing *Ihh* ([Fig. 5 F](#fig5){ref-type="fig"}), *PTHrP-R* ([Fig. 5 H](#fig5){ref-type="fig"}), and *Col10* ([Fig. 5 J](#fig5){ref-type="fig"}) largely overlap each other. Thus, even though *Ihh*, *Runx2*, and *Col10* are expressed, which indicates hypertrophic differentiation, the characteristic hypertrophic cell morphology and organization is missing in S1P*^cko^* mice.

These results indicate that the loss of S1P does not prevent the molecular program necessary for hypertrophic differentiation. Rather, the loss of S1P appears to affect cell morphology and may affect matrix production. Therefore, we analyzed the expression of the matrix genes *Col2* and *aggrecan* (*Agc1*) and *MMP13* and *Col10* in the E14.5 humerus ([Fig. 6](#fig6){ref-type="fig"}). At E14.5, chondrocyte hypertrophy is clearly established in the WT, characterized by the expression of *Col10* ([Fig. 6 A](#fig6){ref-type="fig"}) and the lack of *Col2* ([Fig. 6 C](#fig6){ref-type="fig"}) and *Agc1* ([Fig. 6 E](#fig6){ref-type="fig"}) expression in hypertrophic cells. In S1P*^cko^* mice, however, expression of *Col2* ([Fig. 6 D](#fig6){ref-type="fig"}) and *Agc1* ([Fig. 6 F](#fig6){ref-type="fig"}) is maintained into the zone of *Col10*-expressing cells ([Fig. 6 B](#fig6){ref-type="fig"}). Thus, in S1P*^cko^* mice, expression of hypertrophic markers is seen concomitantly with expression of markers for proliferating cells. However, the high levels of *Col2* and *Agc1* expression seen in the columnar cells in WT mice ([Fig. 6, C and E](#fig6){ref-type="fig"}, brackets) are absent in S1P*^cko^* mice. Exit from the cell cycle and the expression of *Runx2* and *Col10* suggest hypertrophic differentiation. But the lack of characteristic hypertrophic morphology and the persistence of *Ihh*, *PTHrP-R*, *Col2*, and *Agc1* into the *Col10*-expressing zone suggest that organized transitions between various cell types are missing; the cells do not respond cohesively to differentiation signals and are therefore unable to organize themselves into structurally discrete zones. Finally, we checked for expression of *MMP13* at E14.5 in S1P*^cko^* cells. *MMP13* is normally expressed by the terminal hypertrophic cells in the growth plate ([@bib6]). WT mice showed considerable expression of *MMP13* ([Fig. 6 G](#fig6){ref-type="fig"}) in the terminal hypertrophic chondrocytes. However, S1P*^cko^* mice exhibit a dramatic decrease in *MMP13* expression in the humerus at E14.5 ([Fig. 6 H](#fig6){ref-type="fig"}). This decrease is not a reflection of delay in differentiation but is maintained at E15.5 in S1P*^cko^* mice ([Fig. 6 J](#fig6){ref-type="fig"}), which suggests a defect in terminal hypertrophic differentiation. However, *MMP13* expression was observed in the perichondrium of S1P*^cko^* mice at E15.5 presumably in the osteoblasts in the exuberant bone collar. These data suggest that S1P is required for the completion of hypertrophic differentiation and organization of the hypertrophic zone.

![**Incomplete hypertrophic chondrocyte differentiation in S1P*^cko^* mice.** In situ hybridization analyses for *Col10* (A and B), *Col2* (C and D), *Agc1* (E and F), and *MMP13* (G and H) on humerus sections at E14.5 and for *MMP13* at E15.5 (I and J). High expression of *Col2* and *Agc1* in the region of columnar chondrocytes (brackets) is absent in S1P*^cko^* mice. Expression of *Col2* and *Agc1* continues into the zone of *Col10*-expressing cells in the S1P*^cko^* humerus. Terminal hypertrophic differentiation, though initiated in some chondrocytes, is absent in S1P*^cko^* mice, as seen by lack of *MMP13* expression. Bar, 500 μm.](jcb1790687f06){#fig6}

Vascular invasion of skeletal elements is absent in S1P^*cko*^ mice
-------------------------------------------------------------------

As demonstrated in the preceding section, hypertrophic differentiation remains incomplete in S1P*^cko^* mice. Therefore, we analyzed posthypertrophic differentiation events. Hypertrophic differentiation is usually accompanied by the mineralization of the ECM, allowing for vascular invasion in a VEGF-dependent manner followed by the removal of hypertrophic cells by apoptosis ([@bib57]). Extensive mineralization of the ECM, as analyzed by von Kossa staining, was observed in both the E15.5 tibia ([Fig. 7 B](#fig7){ref-type="fig"}) and humerus ([Fig. 7 D](#fig7){ref-type="fig"}) of S1P*^cko^* mice, providing a prelude to vascular invasion. In S1P*^cko^* mice, however, extensive abnormal mineralization of the chondrocytes in the humerus and to some extent in the tibia is also seen. Abnormal mineralization is often associated with an increase in apoptosis, which leads to the release of apoptotic bodies ([@bib23]). Using a TUNEL assay, we studied apoptosis in the forelimbs of WT and S1P*^cko^* mice at E13.75, 14.5, and 15.5. A considerable increase in chondrocyte apoptosis is observed in both the humerus ([Fig. 7 F](#fig7){ref-type="fig"}) and scapula ([Fig. 7 H](#fig7){ref-type="fig"}) in S1P*^cko^* mice as compared with the WT at E15.5, but not at E13.75 or 14.5. Next, we performed immunohistochemistry (IHC) for the platelet/endothelial cell adhesion molecule 1 (PECAM-1) antigen to analyze vascular invasion of the mineralized matrix. The WT humerus showed normal vascular invasion demarcating the bone from the nonvascular cartilaginous ends ([Fig. 7 I](#fig7){ref-type="fig"}). PECAM-1 staining is absent within the humerus in S1P*^cko^* mice, suggesting a lack of vascular invasion ([Fig. 7 J](#fig7){ref-type="fig"}); however, it is seen in the bone collar, suggesting a defect only in endochondral bone formation.

![**Increased chondrocyte apoptosis and absence of vascular invasion in the skeletal elements of S1P*^cko^* mice.** von Kossa staining of the tibia (A and B) and humerus (C and D) at E15.5, suggesting normal mineralization of the ECM in S1P*^cko^* mice. The black arrows (B and D) depict areas of abnormal mineralization. Increased chondrocyte apoptosis as detected by a TUNEL assay is seen in the humerus (F) and scapula (H) of S1P*^cko^* mice at E15.5. In E15.5 WT humorus (E) or scapula (G), hardly any apoptosis is observed; some apoptosis is seen at the chondroosseous junction in the humerus (E, white arrows). (I) PECAM-1 IHC showing the presence of blood vessels in the developing bone (b) of the WT humerus and its absence in the cartilage (c) at E15.5. (J) PECAM-1 staining is absent in the diaphysis (d) of the S1P*^cko^* humerus at E15.5 but is evident in the anomalous bone collar (bc). The dotted lines in panels I and J demarcate the humerus from the surrounding tissue and also outline the bone collar in the mutant. Bars: (A--D) 50 μm; (E--J) 200 μm.](jcb1790687f07){#fig7}

Vascular invasion takes place in a VEGF-dependent manner and is needed for the invasion of osteoblastic progenitors and osteoclasts ([@bib36]). Osteoblasts synthesize MMP13 (collagenase) and osteoclasts synthesize MMP9 (gelatinase). The cooperative activity of these two MMPs breaks down the mineralized matrix of the hypertrophic cells and replaces it with bone matrix that is rich in Col I ([@bib47]). Interestingly, both WT and S1P*^cko^* mice demonstrated considerable *VEGF* and *MMP9* expression (Fig. S3, available at <http://www.jcb.org/cgi/content/full/jcb.200708092/DC1>). The presence of *MMP9*-positive osteoclasts in S1P*^cko^* mice was further confirmed by tartrate-resistant acid phosphatase--positive cells in the bone collar (Fig. S3). Because of the lack of endochondral bone development in S1P*^cko^* mice, we analyzed whether S1P*^cko^* mice have a defect in osteoblast formation. Osteoblastogenesis would be expected to be normal in the mutants because of the proper onset of *BSP*-expressing bone collar ([Fig. 4 I](#fig4){ref-type="fig"}) and the expression of *Runx2* ([Fig. 5 D](#fig5){ref-type="fig"}). To extend these findings, we analyzed the expression of *Col1*, the bone-specific *osteocalcin*, and *alkaline phosphatase*, which is vital to bone morphogenesis, in S1P*^cko^* mice (Fig. S3). Expression of *Col1*, *osteocalcin*, and *alkaline phosphatase* is observed in S1P*^cko^* mice, though only in the bone collar because of the lack of endochondral bone. These observations indicate that S1P*^cko^* mice have the ability to produce normal osteoblast progenitors and that the lack of endochondral bone is caused by the inability of the cartilage matrix to support osteoblast invasion.

Abnormal Col II properties in S1P^*cko*^ mice
---------------------------------------------

Several lines of evidence suggest that matrix abnormalities are primarily responsible for the S1P*^cko^* phenotype. First, chondrocytes are more densely packed in S1P*^cko^* skeletal elements. Second, Ihh signaling is intact, as indicated by *Ptc-1* and *PTHrP* expression, although *Ptc-1* expression appears to be slightly disorganized. Third, it is unlikely that the reduced *MMP13* expression seen in S1P*^cko^* mice is responsible for the lack of endochondral bone, as the targeted inactivation of *MMP13* in mice does not prevent endochondral bone formation ([@bib20]; [@bib45]). Finally, the increase in chondrocyte apoptosis in S1P*^cko^* mice that is suggestive of an abnormal matrix is also seen in transgenic mice lacking Col II ([@bib51]). S1P may thus play a role in the deposition of a normal cartilage. To assess abnormalities in the matrix, we studied the properties of the Col II protein, which is a major cartilage component. First, we attempted to extract the Col II protein from E17.5 WT and S1P*^cko^* cartilage by pepsin digestion after extraction of the proteoglycans by 4 M Gu-HCl. After pepsin digestion, the extract was concentrated and equal concentrations of protein from each sample were subjected to SDS-PAGE and analyzed by Western blotting for Col II (using the IIF antibody that detects the triple helical domain of Col II) and Col X protein ([Fig. 8 A](#fig8){ref-type="fig"}). We were able to extract the full-length Col II from the WT head ([Fig. 8 A](#fig8){ref-type="fig"}, lane 3) and the rest of its skeleton ([Fig. 8 A](#fig8){ref-type="fig"}, lane 1). Notably, we were not able to extract the full-length Col II from any of the S1P*^cko^* skeletal elements ([Fig. 8 A](#fig8){ref-type="fig"}, lanes 2 and 4). In some preparations, some lower molecular weight proteins with immunoreactivity to the IIF antibody are seen (unpublished data). But we were unable to extract comparable amounts of the full-length Col II protein in any of our attempts. By Western blotting analysis of twofold dilutions of the pepsin-digested material, we determined that we were extracting ∼64-fold less of the full-length Col II protein from the S1P*^cko^* mice as compared with WT (unpublished data). In contrast, we were able to extract comparable amounts of the Col X protein from both WT and S1P*^cko^* mice.

![**Abnormal Col II properties in S1P*^cko^* mice.** (A) The cartilage from the spine and limbs (1 and 2) or head (3 and 4) of WT (1 and 3) and S1P*^cko^* (2 and 4) mice were pepsin digested after extraction of the proteoglycans with Gu-HCl. The pepsin-released collagens were concentrated and analyzed by SDS-PAGE and Western blotted for Col II (top) and Col X (bottom) proteins. (B) Western blot analysis for the Col II procollagen (Pro-Col II) from the medium of WT (2) or S1P*^cko^* (3) chondrocyte cultures (1 is control medium before the addition of chondrocytes). IHC for the Col II (C and D; IIF antibody) and Col IIA (E and F; IIA antibody) proteins demonstrating their expression in the mutant mice. Detection of protein was performed with DAB. Polarized light microscopy to analyze the birefringence properties of the Col II fibrillar network in the E16.5 humerus of WT (G) and S1P*^cko^* (H) mice. White line in B indicates that intervening lanes have been spliced out. Bar, 500 μm.](jcb1790687f08){#fig8}

These data suggested that the Col II protein is less abundant or absent in S1P*^cko^* mice. However, we were able to detect the full-length Col II procollagen in the medium of cultured chondrocytes from both E18.5 WT and S1P*^cko^* mice by Western blotting ([Fig. 8 B](#fig8){ref-type="fig"}). Furthermore, by IHC analysis, Col II protein was detected in the humerus of E18.5 WT ([Fig. 8 C](#fig8){ref-type="fig"}) and S1P*^cko^* ([Fig. 8 D](#fig8){ref-type="fig"}) mice. We also tested for the presence of the Col IIA protein (using the IIA antibody that detects exon 2), which is normally detected in the matrix surrounding chondroprogenitor cells and early immature chondrocytes. The Col IIA isoform was detected in both WT ([Fig. 8 E](#fig8){ref-type="fig"}) and S1P*^cko^* mice ([Fig. 8 F](#fig8){ref-type="fig"}). In the WT, detection of Col IIA protein was strongest at the location of the early, immature chondrocytes close to the articular surface. Surprisingly, in S1P*^cko^* mice, Col IIA was detected throughout the length of the humerus ([Fig. 8 F](#fig8){ref-type="fig"}). Therefore, we analyzed whether alternative splicing of the procollagen mRNA from *Col2A* to *Col2B* was normal in S1P*^cko^* mice. For this analysis, we performed in situ hybridization using highly specific 24-mer oligonucleotide probes spanning the exon 1 and 2 junction for *Col2A* analysis and the exon 1 and 3 junction for the *Col2B* analysis. Splicing of both *Col2A* and *2B* mRNA was, however, found to be normal in S1P*^cko^* mice (Fig. S4, available at <http://www.jcb.org/cgi/content/full/jcb.200708092/DC1>). These data suggested that Col II synthesis was taking place in S1P*^cko^* mice, although the turnover of Col II is abnormal, as total Col II and Col IIA was detected throughout the length of the humerus. These data also suggested that the organization of the cartilage ECM may be abnormal. Therefore, to assess the structural organization of the collagens in the ECM, we first determined the birefringent properties of the Col II fibrils in both WT and S1P*^cko^* mice. A marked decrease in the birefringence of the collagen network was observed in the E16.5 humerus in S1P*^cko^* mice ([Fig. 8 H](#fig8){ref-type="fig"}) as compared with the WT ([Fig. 8 G](#fig8){ref-type="fig"}), which suggests a poorly organized collagen fibrillar network in the cartilage of S1P*^cko^* mice. This reduced birefringence in S1P*^cko^* mice is similar to that seen in mice with inactivation of the *Col2a1* gene ([@bib29]). These data together suggest that one of the molecular defects caused by a lack of S1P is the abnormal organization of the Col II protein, which results in an abnormal cartilage that prevents vascular invasion and endochondral ossification in S1P*^cko^* mice.

To pursue this observation further, we performed double-labeled immunofluorescence analysis with the IIA and IIF antibodies ([@bib59]) to study the organization and localization of the Col II protein ([Fig. 9](#fig9){ref-type="fig"}). In the WT, the secretion and incorporation of Col IIA into the matrix is seen as a well-formed and organized green lattice network. Localization of the collagen triple helical domains is seen as red immunofluorescence, which in the WT is seen as a distinct red lattice network with hardly any yellow colocalization signals from the two antibodies, suggesting that the red lattice is almost entirely made of Col IIB protein. As expected in the WT, the presence of Col IIA is stronger in the matrix surrounding the early immature chondrocytes ([Fig. 9 B](#fig9){ref-type="fig"}) and the presence of Col IIB is stronger around the more mature columnar chondrocytes ([Fig. 9 C](#fig9){ref-type="fig"}). In S1P*^cko^* mice ([Fig. 9, F and G](#fig9){ref-type="fig"}), the organization of the Col IIA lattice network appears normal, though it is also prominent in the matrix surrounding mature chondrocytes ([Fig. 9 G](#fig9){ref-type="fig"}). However, in the matrix surrounding early chondrocytes ([Fig. 9 F](#fig9){ref-type="fig"}), well-formed organization of Col IIB fibrils (red) is considerably reduced and the majority of the signal appears to be caused by colocalization (yellow), suggesting that both antibodies are detecting primarily Col IIA and very little Col IIB. In the matrix surrounding more mature chondrocytes ([Fig. 9 G](#fig9){ref-type="fig"}), the lattice network is primarily green with very little incorporation of Col IIB (red signaling) into the lattice network of the ECM. Most of the Col IIB protein ([Fig. 9 G](#fig9){ref-type="fig"}, arrows) is seen trapped inside the cell. The lack of matrix accumulation can be seen more clearly in cross sections of the ribs (at E18.5) in S1P*^cko^* mice ([Fig. 9 H](#fig9){ref-type="fig"}). Again, primarily colocalization signals (yellow) and the substantial absence of matrix when compared with the WT ([Fig. 9 D](#fig9){ref-type="fig"}) is observed, which showed abundant matrix (red) with yellow colocalization signals restricted to the rim of the rib.

![**Abnormal collagen fibril deposition and ER stress in S1P*^cko^* mice.** Double-labeled immunofluorescence studies with the IIA and IIF antibodies in the E15.5 humerus (A--C and E--G) and E18.5 rib cross sections (D and H) in WT (A--D) and S1P*^cko^* (E--H) mice showing abnormal collagen fibril deposition and entrapment of Col IIB protein (G, arrows) within the cell in the mutant mice. B and F are higher magnification images of the regions outlined by the black boxes in A and E, and C and G are higher magnification images of the regions outlined by the white boxes. In the WT, colocalization of IIA and IIF antibodies is seen only at the rim of the rib (D, arrow). Colors represent antibody localizations as follows: green, Col II exon 2 (IIA); red, Col II triple helical domain (IIF); yellow, colocalization of both antibodies. Electron microscopy images of the cartilage matrix and chondrocytes of the proliferative zone in E15.5 WT (I--K) and S1P*^cko^* (L--N) tibia. J and M emphasize the cartilage ECM, showing the decrease in collagen fibrillar density in the S1P*^cko^* matrix, and K and N emphasize the intracellular organization, particularly the engorged and fragmented ER in the mutant mice (black arrows). The engorged ER in the mutant is filled with materials that appear homogenously or heterogeneously stained with partially crystalline appearance (N, white arrow). Bars: (A and E) 500 μm; (B--D and F--H) 84 μm; (I and L) 2 μm; (J and M) 2 μm; (K and N) 1 μm.](jcb1790687f09){#fig9}

These data suggested that in S1P*^cko^* mice, although there is no problem in the expression and secretion of Col IIA and its incorporation into the matrix, the expression and/or secretion of Col IIB is abnormal and results in a matrix with considerably reduced levels of Col IIB and therefore an inability to extract Col II from the matrix ([Fig. 8 A](#fig8){ref-type="fig"}). To understand the mechanism for this defect, we performed electron microscopic analysis of tibia ([Fig. 9, I--N](#fig9){ref-type="fig"}) and humerus (not depicted) from E15.5 WT and S1P*^cko^* mice. In the WT ([Fig. 9, I--K](#fig9){ref-type="fig"}), the cartilage from the proliferative zone showed the presence of well-formed and abundant, homogenous Col II fibrils surrounding normal chondrocytes. In S1P*^cko^* mice, however ([Fig. 9, L--N](#fig9){ref-type="fig"}), the distribution of collagen fibril density is irregular and considerably reduced. The ER is drastically enlarged, irregular in shape, and fragmented and also often found filled with granular, homogenous, or heterogenously stained material that also sometimes appears to be crystalline. Similar observations were seen in the chondrocytes/ECM of the articular, hypertrophic, and joint cartilage regions in S1P*^cko^* mice. These data suggest the induction of ER stress in chondrocytes in S1P*^cko^* mice, presumably caused by the excessive demand for complex matrix protein synthesis required for cartilage deposition, and a requirement for S1P activity to alleviate ER stress during matrix protein synthesis and deposition.

Discussion
==========

In this paper, we have established the importance of S1P to cartilage deposition and endochondral ossification. Null mice with a loss of S1P in all tissues were found to be embryonic lethal at a very early stage and therefore did not provide a suitable avenue to study its contribution to cartilage and bone development ([@bib52]). Our studies on S1P*^cko^* mice have allowed us to focus on the requirement of S1P in chondrocyte differentiation and the genesis of a normal endochondral skeleton. Cartilage-specific disruption of S1P in S1P*^cko^* mice results in total lack of endochondral bone in all skeletal elements that exhibit longitudinal bone growth through endochondral ossification.

The lack of endochondral bone seen in S1P*^cko^* mice is also seen in *Ihh* ([@bib44]) and *Runx2* null mice ([@bib24]; [@bib37]). In both these mutants, endochondral bone development is hampered because of a defect in osteoblastogenesis. Both *Ihh* and *Runx2* null mice also suffer from varying degrees of an abnormal chondrocyte differentiation program ([@bib19]; [@bib22]). In S1P*^cko^* mice, we initially expected that the phenotype could have arisen because of a defect in the Ihh signaling pathway. However, our data suggest that S1P*^cko^* mice have an intact Ihh signaling pathway, as indicated by the expression of *Ptc-1* and *PTHrP* in S1P*^cko^* skeletal elements. However, the mislocalization of *Ptc-1*--expressing cells leaves open the possibility that S1P has an effect on the activity level and/or diffusion of Ihh. The morphological phenotype that sets S1P*^cko^* mice apart from *Ihh* and *Runx2* null mice is that S1P*^cko^* mice exhibit an exuberant bone collar showing normal osteoblastogenesis. Elimination of S1P results in an uncoupling of normal endochondral bone formation from cortical bone formation. Thus, like Ihh and Runx2, S1P is a major positive regulator of endochondral ossification. Expression of *S1P* is observed in the perichondrium in the WT. However, in S1P*^cko^* mice, S1P activity would be expected to be absent in the perichondrium because of active Col2-Cre activity in these cells. These data suggest that S1P is not necessary for cortical bone formation. Mice with double knockouts of the transcription factors L-Sox5 and Sox6 also exhibit a lack of endochondral ossification with development of a thick cortical bone ([@bib43]). However, it is unlikely that this pathway is affected in S1P*^cko^* mice, as they exhibit abundant expression of L-Sox5 and Sox6 (unpublished data).

The lack of endochondral bone in S1P*^cko^* mice appears to be caused by an inability of the blood vessels to invade the abnormal, mineralized cartilage in spite of apparently adequate *VEGF* expression. According to the tenets of organogenesis, where development is guided by tissue interactions, the developmental history of a tissue plays an important role in its ability to respond to instructive cues ([@bib7]). Thus, it would be expected that an abnormal cartilage would constrain its ability to respond to instructions from the perichondrium and/or vascular tissue. The genesis of a normal matrix is necessary for proper hypertrophic differentiation and endochondral ossification. Our data suggest that the defects in hypertrophic differentiation and endochondral ossification can be traced to an abnormal matrix in S1P*^cko^* mutants. In S1P*^cko^* mice, the chondrocytes are densely packed and randomly oriented with very little matrix between them. The increased chondrocyte apoptosis seen in S1P*^cko^* mice is also highly indicative of an abnormal cartilage that is unable to support chondrocyte survival. This is similar to the increased apoptosis seen in transgenic mice lacking Col II ([@bib51]). The absence of a proper cartilage could hinder not only the supply of nutrients to the avascular ECM ([@bib18]) but also have profound effects on integrin-mediated pathways and distribution of growth factors ([@bib54]). The inability to extract normal amounts of full-length Col II from cartilage, the decreased birefringence of Col II network, the lack of the Col IIB lattice network, and the considerable reduction in collagen fibrillar density as seen by electron microscopy all attest to the fact that the cartilage is abnormal in S1P*^cko^* mice. S1P*^cko^* mice also exhibit abnormal spine development in that the intervertebral discs are not well formed and lack the gelatinous nucleus pulposus in the center. This is also seen in transgenic mice with a null mutation in the *Col2a1* gene ([@bib2]).

An abnormal cartilage ECM could mask angiogenic signaling by VEGF in spite of the adequate *VEGF* expression that is seen in S1P*^cko^* mice. Given the abnormal characteristics of the cartilage matrix, even if VEGF is not masked, the MMPs may not be able to process and break down the alien matrix in S1P*^cko^* mice. An inability to degrade the matrix is suggested by the persistence of Col IIA in the S1P*^cko^* cartilage, as Col IIA is seen throughout the length of the humerus. These observations are highly suggestive of a lack of structurally intact cartilage matrix in S1P*^cko^* mice that is normally a forerunner for endochondral bone development. Some of the phenotypes seen in S1P*^cko^* mice also bear resemblance to the phenotypes seen in mutants for other matrix proteins. For example, a lack of columnar hypertrophic chondrocytes, disorganized growth plates, chondrodysplasia, and incomplete nucleus pulposus are seen in mice lacking perlecan ([@bib1]; [@bib13]), Agc1 ([@bib50]; [@bib48]), and/or link protein ([@bib49]). These observations clearly attest to the importance of a properly organized matrix for chondrocyte differentiation. However, these mutations exhibit only reduced or delayed endochondral ossification. Thus, it is noteworthy that only the disruption of the *Col2a1* gene ([@bib29]) results in a complete lack of endochondral ossification as seen in S1P*^cko^* mice. These data suggest a convergence of S1P activity with a property of Col II in relation to the cartilage matrix.

Thus, our paper shows that S1P is essential to endochondral ossification. The much accepted role of S1P is that of a proprotein convertase required to activate the transcription factors SREBPs, ATF6, OASIS, and CREBH, the latter three playing vital roles during ER stress response. Given that the knockout of the SREBP molecules has not exhibited any known defect in bone morphogenesis in mice that escape embryonic lethality ([@bib42]; [@bib30]), it seems unlikely that the phenotype in S1P*^cko^* mice is manifested through SREBPs. Furthermore, in the zebrafish *gonzo* phenotype, knockdown of SCAP (the lipid sensor) results only in strong lipid phenotypes with normal cartilage ([@bib41]). These data suggest that the abnormal cartilage phenotype in S1P*^cko^* mice is mediated by lipid-independent pathways. Given the engorgement and fragmentation of the ER in S1P*^cko^* mice, it seems likely that S1P is required to activate ER stress signaling (ERSS) in response to the hyperproduction of complex cartilage matrix proteins seen in chondrocytes. Unlike other studies ([@bib46]), it is noteworthy that the ER stress observed in S1P*^cko^* mice is not caused by the introduction of any mutant matrix protein but by the inability of the chondrocyte to respond to ER stress because of a lack of S1P activity. Based on these data we propose that the ER stress response is part of the vital protein processing machinery in normal chondrocytes and is essential for normal matrix production ([Fig. 10](#fig10){ref-type="fig"}). In a normal chondrocyte differentiation program, chondroprogenitor cells do not require ER stress response because of the relatively low level of protein synthesis and secrete Col IIA into the matrix. However, on differentiation into chondrocytes, to alleviate the stress caused by the high demand for complex matrix protein synthesis, the chondrocytes initiate ERSS, a mechanism that requires S1P to activate ATF6, OASIS, or CREBH (currently the three known ER stress signal transducers that require activation by S1P). This allows for the deposition of normal cartilage followed by endochondral ossification. In S1P*^cko^* mice, chondroprogenitor cells do not show any defect in the secretion of Col IIA either because of the level of Col IIA synthesis or the different dynamics of Col IIA secretion. However, upon differentiation into chondrocytes and a switch to the alternatively spliced form Col IIB and the concomitant increase in protein synthesis and secretion, S1P*^cko^* mice are unable to initiate the ER stress response because of an inability to activate the appropriate transcription factors in the absence of S1P. This results in the engorgement and fragmentation of the ER followed by poor Col IIB secretion into the matrix, which results in the matrix acquiring the properties typically seen on disruption of the *Col2a1* gene. Other cell types, such as the periosteal cells, which lack S1P but do not require the same ER stress response, are able to synthesize bone, as seen in S1P*^cko^* mice. Thus, chondrocytes in this respect are like the differentiating plasma cells, which turn on the unfolded protein response to alleviate ER stress and optimize antibody secretion ([@bib12]), or exocrine glands, where the ER stress response is necessary for the full development of the secretory machinery ([@bib27]).

![**A model for the requirement of S1P in the ER stress response for the genesis of a normal cartilage matrix.** TF, transcription factor.](jcb1790687f10){#fig10}

In the zebrafish S1P *gonzo* mutants, ER stress and unfolded protein response were reported to be normal based on in situ hybridization to two mRNA sequences known to be downstream of ATF6. In light of recent discoveries, this assessment may have been misleading. First, the analysis in *gonzo* mutants involved the in situ analysis of the full-length *XBP1* mRNA and not the specific splice form necessary for ER stress response ([@bib56]; [@bib4]). Second, the presence of immunoglobulin heavy chain binding pretien (BiP) chaperone does not ensure an adequate ERSS in chondrocytes, and BiP can be regulated by other transcription factors such as NF-Y ([@bib55]). In preliminary experiments, we also detect BiP expression in both WT and S1P*^cko^* mice (unpublished data). Lastly, besides ATF6, at least two other ERSS transcription factors, OASIS and CREBH, are regulated by S1P. Collectively, these observations suggest the requirement of a new specialized pathway for regulation of matrix protein synthesis in chondrocytes. We are currently investigating these possibilities using our mouse model to provide a more complete picture of the utility of S1P in ER stress response, matrix synthesis, and endochondral bone formation.

Materials and methods
=====================

Generation of S1P*^cko^* mice
-----------------------------

To generate S1P*^cko^* mice, S1P*^f/f^* mice (mice homozygous for the S1P*^flox^* allele in which the exon 2 of S1P is floxed, provided by J.D. Horton, University of Texas Southwestern Medical Center, Dallas, TX; [@bib52]) were bred with Col2-Cre (where the Cre recombinase is under the influence of the cartilage-specific *Col2a1* promoter, limiting its expression primarily to cartilage; a gift of D. Ornitz, Washington University School of Medicine, St. Louis, MO; [@bib21]) transgenic mice of the C57BL/6J strain to produce S1P^*f*/+^;Col2-Cre mice (mice heterozygous for the S1P*^flox^* allele and positive for the Col2-Cre transgene). The S1P^*f*/+^;Col2-Cre mice were bred with S1P*^f/f^* mice to generate S1P*^cko^* mice. Genotypes were verified by PCR analysis of tail-derived DNA.

Isolation of collagens from WT and S1P*^cko^* mice
--------------------------------------------------

The isolation of collagens was done from E17.5 WT and S1P*^cko^* mice using a modification of previously published protocols ([@bib32]). In brief, E17.5 embryos were skinned and eviscerated, and the head was processed separately from the rest of the body. The spine/limbs and head were frozen and crushed, and the proteoglycans were extracted with 4 M Gu-HCl in 0.05 M Tris-HCl, pH 7.5, containing 0.01 M EDTA and a 1× complete protease inhibitor cocktail (Roche), for 36 h at 4°C. The cartilage residues left after proteoglycan extraction were washed with cold water and digested with 1 mg/ml pepsin in 0.5 M acetic acid for 24 h at 4°C. The digest was then concentrated with centricon30 (Millipore) to ∼250 μl, dialyzed against 0.05 M Tris-HCl, pH 7.5, buffer containing 0.4 M NaCl and 5 mM EDTA, and stored at −20°C. Equal concentrations of protein preparations (determined by Bio-Rad Laboratories protein assay) from WT and S1P*^cko^* mice were separated by SDS-PAGE followed by Western blotting for Col II (using the previously described rat antibody IIF against bovine Col II triple helical domain; [@bib59]) and Col X proteins (EMD). The molecular weight marker used in SDS-PAGE was BenchMark prestained protein ladder (Invitrogen).

Primary chondrocyte cultures from WT and S1P*^cko^* mice
--------------------------------------------------------

To study the biosynthesis and secretion of the Col II protein in vitro, primary cultures from WT and S1P*^cko^* mice were established. Chondrocytes were isolated from the sternum and ribs of WT and S1P*^cko^* mice as described previously ([@bib28]). In brief, rib cages were taken from WT or S1P*^cko^* mice and treated with 2 mg/ml pronase (Roche) at 37°C for 30 min followed by 3 mg/ml collagenase (Roche) treatment in the presence of 8% CO~2~ for 1.5 h at 37°C or until all soft tissues are detached from the cartilage. The cartilage was then separated from the soft tissues and treated again with 3 mg/ml collagenase for 4 h at 37°C in the presence of 5% CO~2~. The digest was filtered through a cell strainer to remove undigested bony parts and the cells were then pelleted by centrifugation, washed with 1× PBS, and plated at a density of 2.5 × 10^5^ per cm^2^ in DME with 10% heat-inactivated serum, 2% penicillin/streptomycin (Sigma-Aldrich), and 0.25 mM sodium ascorbate. 50 μl of media from the WT and S1P*^cko^* chondrocyte cultures was harvested at regular intervals and separated by 7.5% SDS-PAGE (Bio-Rad Laboratories), and the type II procollagen was detected by Western blotting using the IIF antibody.

Morphological and histological analysis
---------------------------------------

Whole-mount skeletal staining of embryos by alcian blue and alizarin red was performed as described previously ([@bib33]). For histological and in situ hybridization analyses on sections, embryonic tissues were collected at various embryonic time points and processed and sectioned as described previously ([@bib16]). Histological analyses were done primarily by Safranin O, Fast green, and hematoxylin staining. Detection of mineralization was performed by staining with 1% silver nitrate as per the von Kossa method, followed by counterstaining with Methyl green. In situ hybridization analyses were performed using ^35^S-labeled riboprobes as described previously ([@bib31]). All in situ probes with the exception of Agc1 were provided by F. Long (Washington University School of Medicine) and have been described by [@bib16] and references therein. The Agc1 in situ probe (a gift of E. Vuorio, University of Turku, Turku, Finland) covering the IGD sequence of the mouse Agc1 has been described previously ([@bib10]). The full-length S1P and the S1P exon 2 in situ probes were derived from a full-length cDNA clone (American Type Culture Collection). For BrdU analyses, pregnant females were injected with BrdU as described previously ([@bib16]), and proliferation of chondrocytes was analyzed using a kit (Invitrogen). For PECAM-1 IHC, embryos were fixed using 4% formaldehyde followed by 30% sucrose infiltration. 10-μm cryostat sections were derived from tissues embedded in OCT (Tissue-Tek; Thermo Fisher Scientific) and IHC was performed using a monoclonal rat anti--mouse PECAM-1 antibody (BD Biosciences). Detection of PECAM-1 was done using HRP-conjugated anti--rat IgG and DAB. Methyl green was used for counterstaining. Detection of apoptosis was performed by a TUNEL assay using the in situ cell death detection kit (Roche) according to the manufacturer\'s instructions. Nuclei were counterstained with DAPI and sections were examined by fluorescence microscopy. Tartrate-resistant acid phosphatase--positive cells were stained using standard procedures with methyl green as counterstain. Study of the birefringence of collagen fibers by polarized light microscopy was done on 5-μm-thick paraffin-embedded sections as described previously ([@bib29]). Detection of total Col II protein by IHC was done on 5-μm-thick paraffin-embedded sections at E15.5 and 18.5 stages using the IIF antibody and procedure described previously ([@bib59]), with the exception that detection was done using an HRP-conjugated goat anti--rat secondary antibody and a DAB substrate (Invitrogen). Detection of Col IIA protein was done similarly with the previously described rabbit antisera against recombinant human type IIA-GST (IIA; [@bib35]; [@bib59]) and an HRP-conjugated goat anti--rabbit secondary antibody. Double-labeled immunofluorescence with IIF and IIA antibodies was performed as described previously ([@bib59]) on paraffin embedded sections, with the exception that the IIA and IIF antibodies (and their corresponding secondary antibodies) were used sequentially with the IIA antibody and its secondary antibody applied first. The secondary antibodies used were goat anti--rabbit Alexa Flour 488 (Invitrogen) and goat anti--rat Alexa Fluor 546 (Invitrogen). Images for double immunofluorescence were collected with a 60×, 1.4 NA oil immersion objective using either a scanning laser confocal microscope (for E18.5 ribs cross sections; MRC600; Bio-Rad Laboratories) mounted on a microscope (Eclipse E800; Nikon) and LaserSharp 2000 software (Bio-Rad Laboratories) or a camera (2000R Fast1394; Retiga)and Q Capture Pro (for limbs; QImaging). All other sections (in situ/histology) were viewed with a microscope (BX51; Olympus) using a 10× objective (all in situ analysis) or 20 and 40× objectives (for stained sections or IHC), and images were captured with the digital camera (DP70; Olympus) using DP controller software (Olympus). For in situ analysis, pictures of hybridization signals were hued red and superimposed on toluidine blue--counterstained images using Photoshop (Adobe).

Online supplemental material
----------------------------

Fig. S1 shows the lack of endochondral ossification in the femur, ribs, sternum, and spine of S1P*^cko^* mice. Fig. S2 shows the abnormal hypertrophic differentiation in S1P*^cko^* mice. Fig. S3 shows normal *VEGF* and *MMP9* expression and normal osteoblastogenesis in S1P*^cko^* mice. Fig. S4 shows normal *Col2* mRNA splicing in S1P*^cko^* mice. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.200708092/DC1>.
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